| Trial ID: | L0036 |
| Source ID: | NCT03550534
|
| Associated Drug: |
Calcium Carbonate
|
| Title: |
The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Diseases
|
| Interventions: |
DRUG: Calcium Carbonate|DRUG: Placebo oral capsule
|
| Outcome Measures: |
Primary: Serum Fibroblast Growth Factor 23 (FGF-23), Serum FGF23 (pg/ml) as cardiovascular risk factor in chronic kidney disease (CKD) was measured and compared between 2 groups before and after intervention, 12 weeks | Secondary: Serum Calcium Level, Serum calcium level (mg/dl) was measured and compared between 2 groups before and after intervention, 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: Indonesia University | Collaborators: Dr Cipto Mangunkusumo General Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
46
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
|
| Start Date: |
2015-11-06
|
| Completion Date: |
2016-12-11
|
| Results First Posted: |
|
| Last Update Posted: |
2018-06-08
|
| Locations: |
dr. Cipto Mangunkusumo Hospital, Jakarta Pusat, DKI Jakarta, 10430, Indonesia
|
| URL: |
https://clinicaltrials.gov/show/NCT03550534
|
